SE9301732D0 - NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS - Google Patents

NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS

Info

Publication number
SE9301732D0
SE9301732D0 SE9301732A SE9301732A SE9301732D0 SE 9301732 D0 SE9301732 D0 SE 9301732D0 SE 9301732 A SE9301732 A SE 9301732A SE 9301732 A SE9301732 A SE 9301732A SE 9301732 D0 SE9301732 D0 SE 9301732D0
Authority
SE
Sweden
Prior art keywords
aminotetralins
monosubstituted
esters
centrally acting
new centrally
Prior art date
Application number
SE9301732A
Other languages
Swedish (sv)
Inventor
Vilhelm *Wikstroem Haakan
Original Assignee
Haakan Wilhelm Wikstroem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haakan Wilhelm Wikstroem filed Critical Haakan Wilhelm Wikstroem
Priority to SE9301732A priority Critical patent/SE9301732D0/en
Publication of SE9301732D0 publication Critical patent/SE9301732D0/en
Priority to PCT/SE1994/000465 priority patent/WO1994026703A1/en
Priority to AU68110/94A priority patent/AU6811094A/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A compound of formula (1) or pharmaceutically acceptable acid addition salts thereof, wherein R1 is H, (C1-C8) alkyl, alkenyl, alkynyl, cyclopropylalkyl or (C1-C8) haloalkyl; X is CH2, O or S; R2-SO2-O is in position 5, 6, 7 or 8 and R2 is CF3, CF2CF3, C1-C8 alkyl, substituted aryl (e.g. 4-toluyl); R3 is H, CH3 or CH2CH3. When R3 is CH3 or CH2CH3, it is always in a cis-relationship with respect to the 2-amine substituent.
SE9301732A 1993-05-18 1993-05-18 NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS SE9301732D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9301732A SE9301732D0 (en) 1993-05-18 1993-05-18 NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS
PCT/SE1994/000465 WO1994026703A1 (en) 1993-05-18 1994-05-18 New centrally acting 5-, 6-, 7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins and related structures
AU68110/94A AU6811094A (en) 1993-05-18 1994-05-18 New centrally acting 5-, 6-, 7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins and related structures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9301732A SE9301732D0 (en) 1993-05-18 1993-05-18 NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS

Publications (1)

Publication Number Publication Date
SE9301732D0 true SE9301732D0 (en) 1993-05-18

Family

ID=20390003

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9301732A SE9301732D0 (en) 1993-05-18 1993-05-18 NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS

Country Status (3)

Country Link
AU (1) AU6811094A (en)
SE (1) SE9301732D0 (en)
WO (1) WO1994026703A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (en) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
DE10334188B4 (en) 2003-07-26 2007-07-05 Schwarz Pharma Ag Use of rotigotine to treat depression
DE10359528A1 (en) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S) -2-N-propylamino-5-hydroxytetralin as a D3 agonist therapeutic
DE10361258A1 (en) 2003-12-24 2005-07-28 Schwarz Pharma Ag Use of substituted 2-aminotetralins for the preventive treatment of Parkinson's disease
DE102004014841B4 (en) 2004-03-24 2006-07-06 Schwarz Pharma Ag Use of rotigotine for the treatment and prevention of Parkinson-Plus syndrome
GB0426061D0 (en) * 2004-11-26 2004-12-29 Pfizer Ltd Chroman compounds
EP2215072B1 (en) 2007-11-28 2015-09-02 UCB Pharma GmbH Polymorphic form of rotigotine
IT1392387B1 (en) * 2008-09-26 2012-03-02 Solmag S P A Ora Fidia Farmaceutici S P A PROCESS FOR ROTIGOTINE PREPARATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605504D0 (en) * 1986-12-19 1986-12-19 Astra Laekemedel Ab NOVEL CHROMAN DERIVATIVES
ZA901277B (en) * 1989-02-27 1991-10-30 Lilly Co Eli Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
SE8901889D0 (en) * 1989-05-26 1989-05-26 Astra Ab NOVEL 8-SUBSTITUTED-2-AMINOTETRALINES
WO1992006967A1 (en) * 1990-10-12 1992-04-30 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
SE8904361D0 (en) * 1989-12-22 1989-12-22 Astra Ab NEW CHROMAN AND THIOCHROMAN DERIVATIVES

Also Published As

Publication number Publication date
AU6811094A (en) 1994-12-12
WO1994026703A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
NO170008C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF TETRALINESTERS OF PHENOLES OR BENZONIC ACIDS WITH RETINOID SIMILAR ACTIVITY
ES2075162T3 (en) ACETYLENE DISSTITUTED WITH A PHENYL GROUP AND A CHROMANYL GROUP SUBSTITUTED IN POSITION 2, THIOCHROMANILE OR 1,2,3,4-TETRAHYDROKINOLINYL THAT HAVE ACTIVITY SIMILAR TO THAT OF RETINOIDS.
AR246516A1 (en) Quinazoline derivatives
FI881985A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT VERKANDE (S, S, S) -ISOMERER AV SUBSTITUERADE ACYLDERIVAT AV 1,2,3,4-TETRAHYDROISOKINOLIN-3-CARBOXYLSYROR.
CA2128205A1 (en) Methotrexate derivatives
SE9301732D0 (en) NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS
ES8407066A1 (en) 6 Alpha-methylprednisolone derivatives.
KR890014435A (en) Phenoxyalkylcarboxylic acid derivatives and preparation method thereof
CA2023944A1 (en) Use of phospholipid derivatives as antiviral pharmaceutical and new phospholipids
ES2061487T3 (en) MACROLID COMPOUNDS.
CA2029704A1 (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
KR900011709A (en) Novel Tetralin Derivatives
ES2053896T3 (en) 4,5-DIARILTIOIMIDAZOLES 2-SUBSTITUTED ANTI-HYPERCHOLESTEROLESMIC.
DE68906965D1 (en) ANALGETIC PHENOTHIAZINE DERIVATIVES.
DE68905406D1 (en) CHINOLINE COMPOUND.
ES452986A1 (en) 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivative several processes for its preparation and its use as a coronary therapeutic agent
KR860700352A (en) 2-(1-piperazinyl) -4-substituted phenylquinoline derivatives and preparation methods thereof
IE840167L (en) Pyrrole-2-acetylamino acid derivatives
ES2059528T3 (en) MACROLID COMPOUNDS.
BR9406996A (en) Enanciomer process to prepare the same process to cyclize a compound and intermediate compound
TH9117EX (en) Process for making new sulfamool thiophins
MY104099A (en) Anti inflammatory carbinoloimidazoles.
JPS6429369A (en) Oxazoline derivative
JPS6440474A (en) Novel 2-substituted aminothiazole derivative
TH1891B (en) Semi-finished substances such as benzoic acid Type replaced (3 places)